Bausch + Lomb Corp will pay $1.75 billion to acquire a dry-eye drug from Swiss pharmaceutical giant Novartis, the Wall Street Journal reported on Friday.
(Reporting by Leroy Leo in Bengaluru; Editing by Anil D'Silva)
Bausch + Lomb to buy dry-eye drug from Novartis for $1.75 billion - WSJ
2023-06-30 19:19
Bausch + Lomb Corp will pay $1.75 billion to acquire a dry-eye drug from Swiss pharmaceutical giant Novartis,
You Might Like...
Dua Lipa sued over copyright in 'Levitating'
Britain's AI summit: what can it achieve?
MSCI to acquire remaining stake in Burgiss for $697 million in cash
Stellantis to end gearbox production at Vienna plant, 300 jobs impacted
UK Convenes Wall Street Titans at Royal Palaces to Woo Investment
Commonwealth Bank of Australia Cautions on Economy Even as Profit Climbs
UK's NatWest bank showed 'serious failings' over Farage: probe
Most Disagree With Pheu Thai Coalition Government, Poll Shows